IMGN 388

N/A

Report date: 2024/02/05 13:50:45

Base Information

Drug NameIMGN 388
Drug Alias NameCNTO-365IMGN-388CNTO-95-DM4
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > DM4 payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionIntegrin alpha-V/beta-3 antagonistsMicrotubule-associated proteins inhibitors
TargetsIntegrin alpha-V/beta-3Microtubule-associated proteins
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesImmunogen IncCentocor
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunogen Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A